Works by Pinter, Andreas

Results: 100
    1

    Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period Open Access.

    Published in:
    British Journal of Dermatology, 2025, v. 193, n. 1, p. 44, doi. 10.1093/bjd/ljaf032
    By:
    • Warren, Richard B;
    • Lebwohl, Mark;
    • Thaçi, Diamant;
    • Gooderham, Melinda;
    • Pinter, Andreas;
    • Paul, Carle;
    • Gisondi, Paolo;
    • Szilagyi, Balint;
    • White, Katy;
    • Deherder, Delphine;
    • Staelens, Fabienne;
    • Lambert, Jérémy;
    • Strober, Bruce
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Chronische Entzündungserkrankungen in Deutschland: Eine Querschnittanalyse über Begleiterkrankungen und Arzneimitteleinsatz.

    Published in:
    Zeitschrift für Rheumatologie, 2024, v. 83, n. 3, p. 200, doi. 10.1007/s00393-022-01306-1
    By:
    • Leipe, Jan;
    • Schmelz, Renate;
    • Riemekasten, Gabriela;
    • Thaçi, Diamant;
    • Henes, Jörg;
    • Schäkel, Knut;
    • Pinter, Andreas;
    • Sticherling, Michael;
    • Wegner, Joanna;
    • Fusco, Stefano;
    • Linke, Miriam;
    • Weber, Valeria;
    • Manz, Karina C.;
    • Bartz, Holger;
    • Roecken, Marit;
    • Schmidt, Sandra;
    • Hoyer, Bimba F.
    Publication type:
    Article
    17
    18
    19
    20
    21

    S2k‐Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa – Kurzfassung.

    Published in:
    Journal der Deutschen Dermatologischen Gesellschaft, 2024, v. 22, n. 6, p. 868, doi. 10.1111/ddg.15412_g
    By:
    • Zouboulis, Christos C.;
    • Bechara, Falk G.;
    • Fritz, Klaus;
    • Goebeler, Matthias;
    • Hetzer, Frank H.;
    • Just, Elke;
    • Kirsten, Natalia;
    • Kokolakis, Georgios;
    • Kurzen, Hjalmar;
    • Nikolakis, Georgios;
    • Pinter, Andreas;
    • Podda, Maurizio;
    • Rosinski, Kerstin;
    • Schneider‐Burrus, Sylke;
    • Taube, Klaus‐M.;
    • Volz, Thomas;
    • Winkler, Thomas;
    • Kristandt, Anna;
    • Presser, Dagmar;
    • Zouboulis, Viktor A.
    Publication type:
    Article
    22

    S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version.

    Published in:
    Journal der Deutschen Dermatologischen Gesellschaft, 2024, v. 22, n. 6, p. 868, doi. 10.1111/ddg.15412
    By:
    • Zouboulis, Christos C.;
    • Bechara, Falk G.;
    • Fritz, Klaus;
    • Goebeler, Matthias;
    • Hetzer, Frank H.;
    • Just, Elke;
    • Kirsten, Natalia;
    • Kokolakis, Georgios;
    • Kurzen, Hjalmar;
    • Nikolakis, Georgios;
    • Pinter, Andreas;
    • Podda, Maurizio;
    • Rosinski, Kerstin;
    • Schneider‐Burrus, Sylke;
    • Taube, Klaus‐M.;
    • Volz, Thomas;
    • Winkler, Thomas;
    • Kristandt, Anna;
    • Presser, Dagmar;
    • Zouboulis, Viktor A.
    Publication type:
    Article
    23
    24

    Ixekizumab im Vergleich zu Fumarsäureestern und Methotrexat bei der Behandlung der Nagelpsoriasis bei Patienten mit mittelschwerer bis schwerer Psoriasis: Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate‐to‐severe psoriasis

    Published in:
    Journal der Deutschen Dermatologischen Gesellschaft, 2024, v. 22, n. 2, p. 278, doi. 10.1111/ddg.15292_g
    By:
    • Augustin, Matthias;
    • Mrowietz, Ulrich;
    • Willsmann‐Theis, Dagmar;
    • Gerdes, Sascha;
    • Fotiou, Konstantinos;
    • Schuster, Christopher;
    • Mert, Can;
    • Holzkaemper, Thorsten;
    • Behrens, Frank;
    • Pinter, Andreas
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    Generalized pustular psoriasis: overview of the status quo and results of a panel discussion.

    Published in:
    Journal der Deutschen Dermatologischen Gesellschaft, 2022, v. 20, n. 6, p. 753, doi. 10.1111/ddg.14764
    By:
    • Reich, Kristian;
    • Augustin, Matthias;
    • Gerdes, Sascha;
    • Ghoreschi, Kamran;
    • Kokolakis, Georgios;
    • Mößner, Rotraut;
    • Mrowietz, Ulrich;
    • Navarini, Alexander A.;
    • Pinter, Andreas;
    • Schäkel, Knut;
    • Staubach, Petra;
    • Sticherling, Michael;
    • Thaçi, Diamant;
    • Wilsmann‐Theis, Dagmar
    Publication type:
    Article
    31

    Topische Therapie bei Psoriasis vulgaris – ein Behandlungspfad.

    Published in:
    Journal der Deutschen Dermatologischen Gesellschaft, 2019, v. 17, p. 3, doi. 10.1111/ddg.13810
    By:
    • Körber, Andreas;
    • Wilsmann‐Theis, Dagmar;
    • Augustin, Matthias;
    • Kiedrowski, Ralph;
    • Mrowietz, Ulrich;
    • Rosenbach, Thomas;
    • Meller, Stephan;
    • Pinter, Andreas;
    • Sticherling, Michael;
    • Gerdes, Sascha
    Publication type:
    Article
    32
    33
    34

    A Phase IIIb, Multicentre, Interventional, Randomised, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G-PLUS).

    Published in:
    Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/9967747
    By:
    • Passeron, Thierry;
    • Carrascosa, Jose Manuel;
    • Warren, Richard B.;
    • Pinter, Andreas;
    • Romanelli, Marco;
    • Gorecki, Patricia;
    • Efficace, Michela;
    • Fakharzadeh, Steve;
    • Yang, Ya-Wen;
    • Azzabi, Ahlem;
    • Jazra, Maria;
    • Lemos, Katya;
    • Leung, Monica;
    • Chen, Yanqing;
    • Thaçi, Diamant
    Publication type:
    Article
    35
    36
    37

    Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.

    Published in:
    American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 547, doi. 10.1007/s40257-022-00702-2
    By:
    • Silverberg, Jonathan I.;
    • Adam, David N.;
    • Zirwas, Matthew;
    • Kalia, Sunil;
    • Gutermuth, Jan;
    • Pinter, Andreas;
    • Pink, Andrew E.;
    • Chiricozzi, Andrea;
    • Barbarot, Sebastien;
    • Mark, Thomas;
    • Tindberg, Ann-Marie;
    • Weidinger, Stephan
    Publication type:
    Article
    38
    39

    Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO).

    Published in:
    Journal of Dermatological Treatment, 2024, v. 35, n. 1, p. 1, doi. 10.1080/09546634.2024.2350227
    By:
    • Pinter, Andreas;
    • Eyerich, Kilian;
    • Costanzo, Antonio;
    • Garrelts, Alyssa;
    • Schuster, Christopher;
    • Mert, Can;
    • Lampropoulou, Anastasia;
    • Fotiou, Konstantinos;
    • Maul, Julia-Tatjana;
    • Papp, Kim A.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical Trial.

    Published in:
    JAMA Dermatology, 2024, v. 160, n. 9, p. 953, doi. 10.1001/jamadermatol.2024.2463
    By:
    • Eyerich, Kilian;
    • Asadullah, Khusru;
    • Pinter, Andreas;
    • Weisenseel, Peter;
    • Reich, Kristian;
    • Paul, Carle;
    • Sabat, Robert;
    • Wolk, Kerstin;
    • Eyerich, Stefanie;
    • Lauffer, Felix;
    • Angsana, Julianty;
    • Taut, Friedemann J. H.;
    • Kohler, Kristen;
    • Chen, Yanqing;
    • Sendecki, Jocelyn;
    • Leung, Monica W. L.;
    • Wegner, Sven;
    • Personke, Yvonne;
    • Gomez, Mario;
    • Krüger, Nenja
    Publication type:
    Article
    48
    49
    50